Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained S… (NCT07007013) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Impact of Humor Prescription on the Emotional Well-being of Patients With Medically Unexplained Symptoms: A Quasi-experimental Study
Spain28 participantsStarted 2025-09-01
Plain-language summary
This study aims to study the effectiveness of the intervention for medically unexplained symptoms(MUS) in terms of changes in emotional well-being before and after the intervention (humor therapy)
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Participants may be included in the trial if they meet all of the following inclusion criteria:
* Men and women over 18 years of age.
* Diagnosed with the condition under study (see Section 2: Definitions).
* Expected to undergo follow-up for their condition at the study center.
* Ability to participate in the required assessments.
* Legal capacity to provide informed consent.
* Signed informed consent for inclusion in the study, either by the participant or their legal representative.
Exclusion Criteria:
* Participants will be excluded if they meet any of the following exclusion criteria:
* Participants diagnosed with any of the following conditions:
* Severe mental health disorder, as determined by the investigator
* Cognitive impairment of any etiology, as recorded in the medical history
* Treatment for the condition under study using community-based resources prescribed in Primary Care within the past 6 months.
* Cognitive or affective disorders that limit the ability to comply with study procedures.
* Participation in another study involving an experimental intervention during the period of the present trial and/or requiring visit schedules that are incompatible with this trial.
What they're measuring
1
emotional well-being
Timeframe: From baseline to 6 months after ending the intervention
Trial details
NCT IDNCT07007013
SponsorConsorci Sanitari de l'Alt Penedès i Garraf